Subscribe to FDA Safety Communications: Never Miss a Critical Alert
Nov 13 2025
Discover who qualifies for lung cancer screening under new 2023 guidelines. Learn about low-dose CT scans, targeted therapy advances like osimertinib, and how early detection boosts survival rates from 6% to 59%.
Nov 13 2025
Nov 18 2025
Aug 30 2026
Jun 14 2026
Jul 3 2026